Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Rifomycin S
2. Rifampicin S
Molecular Weight | 822.9 g/mol |
---|---|
Molecular Formula | C43H58N4O12 |
XLogP3 | 4 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 5 |
Exact Mass | 822.40512330 g/mol |
Monoisotopic Mass | 822.40512330 g/mol |
Topological Polar Surface Area | 217 A^2 |
Heavy Atom Count | 59 |
Formal Charge | 0 |
Complexity | 1750 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 4 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 6 | |
---|---|
Drug Name | Rifadin |
PubMed Health | Rifampin (Injection) |
Drug Classes | Antitubercular |
Drug Label | RIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin |
Active Ingredient | Rifampin |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 150mg; 300mg; 600mg/vial |
Market Status | Prescription |
Company | Sanofi Aventis Us |
2 of 6 | |
---|---|
Drug Name | Rifampin |
Active Ingredient | Rifampin |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 150mg; 300mg; 600mg/vial |
Market Status | Prescription |
Company | Bedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts |
3 of 6 | |
---|---|
Drug Name | Rimactane |
PubMed Health | Rifampin |
Drug Classes | Antitubercular |
Drug Label | Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i... |
Active Ingredient | Rifampin |
Dosage Form | Capsule |
Route | Oral |
Strength | 300mg |
Market Status | Prescription |
Company | Prosam Labs |
4 of 6 | |
---|---|
Drug Name | Rifadin |
PubMed Health | Rifampin (Injection) |
Drug Classes | Antitubercular |
Drug Label | RIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin |
Active Ingredient | Rifampin |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 150mg; 300mg; 600mg/vial |
Market Status | Prescription |
Company | Sanofi Aventis Us |
5 of 6 | |
---|---|
Drug Name | Rifampin |
Active Ingredient | Rifampin |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 150mg; 300mg; 600mg/vial |
Market Status | Prescription |
Company | Bedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts |
6 of 6 | |
---|---|
Drug Name | Rimactane |
PubMed Health | Rifampin |
Drug Classes | Antitubercular |
Drug Label | Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i... |
Active Ingredient | Rifampin |
Dosage Form | Capsule |
Route | Oral |
Strength | 300mg |
Market Status | Prescription |
Company | Prosam Labs |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-12
Pay. Date : 2013-01-22
DMF Number : 13383
Submission : 1998-09-01
Status : Active
Type : II
Registration Number : 218MF10388
Registrant's Address : Via Angelo Titi, 22/26, Zona ex punto franco, 72100 Brindisi, Italy
Initial Date of Registration : 2006-03-20
Latest Date of Registration :
NDC Package Code : 82297-101
Start Marketing Date : 1973-04-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R0-CEP 2000-337 - Rev 03
Issue Date : 2005-02-18
Type : TSE
Substance Number : 52
Status : Withdrawn by Holder
NDC Package Code : 66075-7960
Start Marketing Date : 1973-04-09
End Marketing Date : 2025-03-07
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13796
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : CEP 2009-275 - Rev 05
Issue Date : 2024-05-27
Type : Chemical
Substance Number : 52
Status : Valid
Date of Issue : 2019-09-09
Valid Till : 2022-09-08
Written Confirmation Number : WC-0197
Address of the Firm :
NDC Package Code : 17337-0031
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-05-13
Pay. Date : 2022-03-29
DMF Number : 36879
Submission : 2022-04-04
Status : Active
Type : II
NDC Package Code : 17337-0031
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13214
Submission : 1998-04-30
Status : Active
Type : II
Date of Issue : 2022-09-30
Valid Till : 2025-09-10
Written Confirmation Number : WC-0201
Address of the Firm :
NDC Package Code : 57297-444
Start Marketing Date : 1998-04-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2009-10-27
Registration Number : 20091027-103-F-48-03
Manufacturer Name : Lupin Limited,
Manufacturer Address : India, T-142, MIDC, Tarapur, Via Boisar, Maharashtra 401 506
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-04
Pay. Date : 2013-09-26
DMF Number : 13663
Submission : 1998-09-01
Status : Active
Type : II
NDC Package Code : 52972-0026
Start Marketing Date : 1998-11-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Chong Kun Dang Bio Co., Ltd.
Registration Date : 2009-01-30
Registration Number : 20090130-103-F-36-01
Manufacturer Name : Chong Kun Dang Bio Co., Ltd._x000D_
Manufacturer Address : 454,486 Biblock 16 Complex, Moknae-dong, Danwon-gu, Ansan-si, Gyeonggi-do (425-100) (368-3, Chungjeong-ro 3-ga, Seodaemun-gu, Seoul (120-756))
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38768
Submission : 2023-09-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13644
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13717
Submission : 1998-09-01
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13398
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-12
Pay. Date : 2013-01-22
DMF Number : 13383
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-04
Pay. Date : 2013-09-26
DMF Number : 13663
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13717
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38768
Submission : 2023-09-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13214
Submission : 1998-04-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13398
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-05-13
Pay. Date : 2022-03-29
DMF Number : 36879
Submission : 2022-04-04
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13796
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13644
Submission : 1998-09-01
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10027
Submission : 1992-12-30
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R0-CEP 2000-337 - Rev 03
Status : Withdrawn by Holder
Issue Date : 2005-02-18
Type : TSE
Substance Number : 52
Certificate Number : CEP 2009-275 - Rev 05
Status : Valid
Issue Date : 2024-05-27
Type : Chemical
Substance Number : 52
Certificate Number : R0-CEP 2004-295 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2008-12-16
Type : Chemical
Substance Number : 52
Registration Number : 218MF10388
Registrant's Address : Via Angelo Titi, 22/26, Zona ex punto franco, 72100 Brindisi, Italy
Initial Date of Registration : 2006-03-20
Latest Date of Registration : 2022-11-30
About the Company : EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Th...
About the Company : Anwita Drugs is a technocrat-driven pharmaceutical company with over 28 years of expertise in designing and developing solid oral dosage forms (OSD), nutraceuticals, and dietary su...
About the Company : Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Indus...
About the Company : Bills Biotech. Is an R&D driven biotechnological company that manufactures Active Pharmaceutical Ingredients through the process of Fermentation, Semi-synthetic and synthetic proce...
About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...
About the Company : Otto Brandes Gmbh was founded in 1923 and is an independent distributor of high quality Pharmaceutical Active Ingredients and excipients for the pharmaceutical industry. We regard ...
About the Company : QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RIFADIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 1982-01-01
Application Number : 50420
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
Brand Name : RIFATER
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG;300MG;120MG
Packaging :
Approval Date : 1994-05-31
Application Number : 50705
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RIFADIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 1982-01-01
Application Number : 62303
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Sweden
Brand Name : Rifadin
Dosage Form : ORAL SUSPENSION
Dosage Strength : 20 MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Isoniazid; Pyrazinamide; Rifampin
Brand Name : Rifater
Dosage Form : Isoniazid+Pyrazinamide+Rifampicin 50+300+120Mg 40 Combined Oral Use
Dosage Strength : 40 cpr riv 50 mg + 300mg + 120 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 300Mg 8 Joined' Oral Use
Dosage Strength : 8 cps 300 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 450Mg 8 Joined' Oral Use
Dosage Strength : 8 cpr riv 450 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 600Mg 1 Unit Parenteral Use
Dosage Strength : 1 ampoule EV 600 mg + 1 ampoule solv 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifinah
Dosage Form : Rifampicin+Isoniazid+150300 Mg 24 Units Of Oral Use
Dosage Strength : 24 cpr riv 300 mg + 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Rifampicinum; Isoniazidum; Pyrazinamidum
Brand Name : Rifater
Dosage Form : Drag
Dosage Strength : 50mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Related Excipient Companies
Excipients by Applications
Global Sales Information
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Isoniazid; Pyrazinamide; Rifampicin
Dosage Form : Isoniazid+Pyrazinamide+Rifampici...
Dosage Strength : 40 cpr riv 50 mg + 300mg + 120 mg
Price Per Pack (Euro) : 10.57
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Sanofi-Aventis (Switzerland) SA
Dosage Form : Drag
Dosage Strength : 150/100
Price Per Pack (Euro) : 38.6
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Sanofi-Aventis (Switzerland) SA
Rifampicin; Isoniazid; Pyrazinamide
Dosage Form : Drag
Dosage Strength : 50mg
Price Per Pack (Euro) : 20.08
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 2% 60Ml Oral Use
Dosage Strength : 1 bottle 60 ml 20 mg/ml syrup
Price Per Pack (Euro) : 2.8
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 300Mg 8 Joined' Oral ...
Dosage Strength : 8 cps 300 mg
Price Per Pack (Euro) : 3.72
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 450Mg 8 Joined' Oral ...
Dosage Strength : 8 cpr riv 450 mg
Price Per Pack (Euro) : 4.86
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 600Mg 1 Unit Parenter...
Dosage Strength : 1 ampoule EV 600 mg + 1 ampoule solv 10 ml
Price Per Pack (Euro) : 9.28
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin+Isoniazid+150300 Mg 2...
Dosage Strength : 24 cpr riv 300 mg + 150 mg
Price Per Pack (Euro) : 9.48
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 150 mg/75 mg/400 mg
Price Per Pack (Euro) : 49.302
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 150 mg/75 mg/400 mg/275 mg
Price Per Pack (Euro) : 73.106
Published in :
Country : Norway
RX/OTC/DISCN :
Market Place
Reply
28 Jun 2024
Reply
25 Jun 2024
Reply
01 Nov 2023
Reply
27 Sep 2023
Reply
28 Jul 2023
Reply
09 May 2023
Reply
05 Oct 2022
Reply
04 Jan 2022
Reply
04 Nov 2021
Reply
14 May 2024
Reply
18 Oct 2023
Reply
21 Oct 2022
Reply
20 Sep 2021
Reply
10 Sep 2021
Reply
17 Aug 2021
Reply
12 Apr 2021
Reply
04 Sep 2018
Reply
17 Aug 2018
REF. STANDARDS & IMPURITIES
CAS Number : 13983-13-6
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : R0800000
Batch No : 4
Price (€) : 79
Storage : +5°C ± 3°C
CAS Number : 13292-46-1
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : R0700000
Batch No : 2
Price (€) : 79
Storage : +5°C ± 3°C
CAS Number : 13983-13-6
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1604202
Current Lot : R001P0
Previous Lot : I1M474 (31-OCT-2015)
NDC Code :
CAS Number : 13292-46-1
Quantity Per Vial :
Price ($) : 230
Catalog Number : 1604009
Current Lot : R039N0
Previous Lot : R000X0 (31-MAY-2017)
NDC Code :
CAS Number : 17555-51-0
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0012.10
Rifampin Quinone (25 mg) (1,4-dideoxy-1,4- di...
CAS Number : 13983-13-6
Quantity Per Vial : 25
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1604202 / R109W 0
CAS Number : 13292-46-1
Quantity Per Vial : 300
Sale Unit : mg
Price : $245.00
Details : Material Origin- Fermentation- Chemical Synth...
Monograph :
Storage :
Code/Batch No : Catalog #1604009 / R124W 0
CAS Number : 125833-03-6
Quantity Per Vial : 25
Sale Unit : mg
Price : $630.00
Details : Material Origin- Fermentation- Chemical Synth...
Monograph :
Storage :
Code/Batch No : Catalog #1604199 / F120C0
ABOUT THIS PAGE
98
PharmaCompass offers a list of Rifampin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rifampin manufacturer or Rifampin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rifampin manufacturer or Rifampin supplier.
PharmaCompass also assists you with knowing the Rifampin API Price utilized in the formulation of products. Rifampin API Price is not always fixed or binding as the Rifampin Price is obtained through a variety of data sources. The Rifampin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rifampin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rifampin, including repackagers and relabelers. The FDA regulates Rifampin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rifampin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rifampin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rifampin supplier is an individual or a company that provides Rifampin active pharmaceutical ingredient (API) or Rifampin finished formulations upon request. The Rifampin suppliers may include Rifampin API manufacturers, exporters, distributors and traders.
click here to find a list of Rifampin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rifampin DMF (Drug Master File) is a document detailing the whole manufacturing process of Rifampin active pharmaceutical ingredient (API) in detail. Different forms of Rifampin DMFs exist exist since differing nations have different regulations, such as Rifampin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rifampin DMF submitted to regulatory agencies in the US is known as a USDMF. Rifampin USDMF includes data on Rifampin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rifampin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rifampin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rifampin Drug Master File in Japan (Rifampin JDMF) empowers Rifampin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rifampin JDMF during the approval evaluation for pharmaceutical products. At the time of Rifampin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rifampin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rifampin Drug Master File in Korea (Rifampin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rifampin. The MFDS reviews the Rifampin KDMF as part of the drug registration process and uses the information provided in the Rifampin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rifampin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rifampin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rifampin suppliers with KDMF on PharmaCompass.
A Rifampin CEP of the European Pharmacopoeia monograph is often referred to as a Rifampin Certificate of Suitability (COS). The purpose of a Rifampin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rifampin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rifampin to their clients by showing that a Rifampin CEP has been issued for it. The manufacturer submits a Rifampin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rifampin CEP holder for the record. Additionally, the data presented in the Rifampin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rifampin DMF.
A Rifampin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rifampin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rifampin suppliers with CEP (COS) on PharmaCompass.
A Rifampin written confirmation (Rifampin WC) is an official document issued by a regulatory agency to a Rifampin manufacturer, verifying that the manufacturing facility of a Rifampin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rifampin APIs or Rifampin finished pharmaceutical products to another nation, regulatory agencies frequently require a Rifampin WC (written confirmation) as part of the regulatory process.
click here to find a list of Rifampin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rifampin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rifampin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rifampin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rifampin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rifampin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rifampin suppliers with NDC on PharmaCompass.
Rifampin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rifampin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rifampin GMP manufacturer or Rifampin GMP API supplier for your needs.
A Rifampin CoA (Certificate of Analysis) is a formal document that attests to Rifampin's compliance with Rifampin specifications and serves as a tool for batch-level quality control.
Rifampin CoA mostly includes findings from lab analyses of a specific batch. For each Rifampin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rifampin may be tested according to a variety of international standards, such as European Pharmacopoeia (Rifampin EP), Rifampin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rifampin USP).